North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 30 of 96
Older
Oldest
Details
LDL
Link Added : NICE TA939: Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer : https://www.nice.org.uk/guidance/ta939
14/03/2024 15:21:25
(DavidS )
UPD
sitematrix Changed from 0 to
14/03/2024 15:20:52
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of advanced melanoma after disease progression with ipilimumab in accordance with NICE.
Approved for the treatment of advanced melanoma not previously tre
14/03/2024 15:20:52
(DavidS )
UPD
Pembrolizumab (Keytruda
®
) NICE TA938
14/03/2024 15:20:52
(DavidS )
UPD
Published from Draft Mode
18/01/2024 10:32:05
(LoweryM )
UPD
sitematrix Changed from 0 to
12/01/2024 13:41:31
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of advanced melanoma after disease progression with ipilimumab in accordance with NICE.
Approved for the treatment of advanced melanoma not previously tre
12/01/2024 13:41:31
(DavidS )
UPD
Pembrolizumab (Keytruda
®
) NHSE SSC2561
12/01/2024 13:41:31
(DavidS )
LDL
Link Added : NICE TA914: Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency : https://www.nice.org.uk/guidance/ta914
11/01/2024 11:34:54
(DavidS )
UPD
sitematrix Changed from 0 to
11/01/2024 11:34:29
(DavidS )
UPD
isDraft Changed from N to Y
11/01/2024 11:34:29
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of advanced melanoma after disease progression with ipilimumab in accordance with NICE.
Approved for the treatment of advanced melanoma not previously tre
11/01/2024 11:34:29
(DavidS )
UPD
Pembrolizumab (Keytruda
®
) NICE TA914 & NHSE SSC2593
11/01/2024 11:34:29
(DavidS )
UPD
Published from Draft Mode
20/11/2023 16:37:08
(LoweryM )
LDL
Link Added : NICE TA904: Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer : https://www.nice.org.uk/guidance/ta904
20/11/2023 13:09:49
(DavidS )
UPD
sitematrix Changed from 0 to
20/11/2023 13:09:23
(DavidS )
UPD
isDraft Changed from N to Y
20/11/2023 13:09:23
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of advanced melanoma after disease progression with ipilimumab in accordance with NICE.
Approved for the treatment of advanced melanoma not previously tre
20/11/2023 13:09:23
(DavidS )
UPD
Pembrolizumab (Keytruda
®
) NICE TA904
20/11/2023 13:09:23
(DavidS )
UPD
Published from Draft Mode
10/10/2023 16:12:01
(LoweryM )
UPD
sitematrix Changed from 0 to
10/10/2023 16:11:50
(LoweryM )
UPD
Pembrolizumab (Keytruda
®
) approved
10/10/2023 16:11:50
(LoweryM )
LDL
Link Added : NICE TA885: Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer : https://www.nice.org.uk/guidance/ta885
10/10/2023 13:42:47
(DavidS )
UPD
sitematrix Changed from 0 to
10/10/2023 13:41:19
(DavidS )
UPD
isDraft Changed from N to Y
10/10/2023 13:41:19
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of advanced melanoma after disease progression with ipilimumab in accordance with NICE.
Approved for the treatment of advanced melanoma not previously tre
10/10/2023 13:41:19
(DavidS )
UPD
Pembrolizumab (Keytruda
®
) NICE TA885
10/10/2023 13:41:19
(DavidS )
LDL
Link Added : MHRA Drug Safety Update (July 2017): Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): reports of organ transplant rejection : https://www.gov.uk/drug-safety-update/nivolumab-opdivo-pembrolizumab-keytruda-reports-of-organ-transplant
11/07/2023 18:30:50
(dmcdermott )
UPD
sitematrix Changed from 0 to
17/11/2022 14:27:42
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of advanced melanoma after disease progression with ipilimumab in accordance with NICE.
Approved for the treatment of advanced melanoma not previously tre
17/11/2022 14:27:42
(DavidS )